Results
|
|
761.
|
|
|
|
762.
|
|
|
|
763.
|
|
|
|
764.
|
|
|
|
765.
|
|
|
|
766.
|
|
|
|
767.
|
|
|
|
768.
|
|
|
|
769.
|
|
|
|
770.
|
|
|
|
771.
|
|
|
|
772.
|
|
|
|
773.
|
|
|
|
774.
|
|
|
|
775.
|
|
|
|
776.
|
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial. [electronic resource] by
- McAuley, Daniel F
- Cross, Lj Mark
- Hamid, Umar
- Gardner, Evie
- Elborn, J Stuart
- Cullen, Kathy M
- Dushianthan, Ahilanandan
- Grocott, Michael Pw
- Matthay, Michael A
- O'Kane, Cecilia M
Producer: 20180411
In:
The Lancet. Respiratory medicine vol. 5
Availability: No items available.
|
|
|
777.
|
|
|
|
778.
|
|
|
|
779.
|
|
|
|
780.
|
|